Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laserRichard Gale, Maria Pikoula, Aaron Y Lee, Spiros Denaxas, Catherine Egan, Adnan Tufail, Paul Taylor, Toks Richard Clare Christopher Usha Alison Narendra Louise Haralabos Sheena Faruque Colin Rehna Vineeth Peck-Lin Aires Andrew Sajjad Geeta Raj Salim Helen Sudeshna Ashish Bobby James Elizabeth Akerele Antcliff Bailey Brand Chakravarthy Davis Dhingra Downey Eleftheriadis George Ghanchi Jones Khan Kumar Lip Lobo Lotery Mahmood Menon Mukherjee Natha Palmer Patra Patwardhan Paul Talks Wilkinson, Toks Akerele, Richard Antcliff, Clare Bailey, Christopher Brand, Usha Chakravarthy, Alison Davis, Narendra Dhingra
See the full list of authors12 June 2020
Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series studyHa-Lim Jeon, Seong Jun Byun, Nicole L Pratt, Janet Sultana, Sang Jun Park, Ju-Young Shin
10 June 2020
Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year resultsJohn F. Payne, Charles C. Wykoff, W. Lloyd Clark, Beau B. Bruce, David S. Boyer, David M. Brown, John F Payne, W Lloyd Clark, John A Wells, David L Johnson, Charles C Wykoff, David M Brown, Matthew Benz, Eric Chen, Richard H Fish
See the full list of authors17 April 2020
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyesThomas A Ciulla, John S Pollack, David F Williams
7 April 2020
OCT-A characterisation of recurrent type 3 macular neovascularisationRiccardo Sacconi, Marco Battista, Enrico Borrelli, Alexandra Miere, Eleonora Corbelli, Vittorio Capuano, Lea Querques, Eric H Souied, Francesco Bandello, Giuseppe Querques
30 March 2020
Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisationHu Xiao, Xiujuan Zhao, Songshan Li, Limei Sun, Wen Xin, Zhirong Wang, Aiyuan Zhang, Junyan Zhang, Xiaoyan Ding
11 March 2020
ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)Sandra Liakopoulos, Georg Spital, Christian K Brinkmann, Tina Schick, Focke Ziemssen, Jessica Voegeler, Mirja Koch, Bernd Kirchhof, Frank G Holz, Daniel Pauleikhoff, Steffen Schmitz-Valckenberg
17 February 2020
Comparison of OCT angiography in children with a history of intravitreal injection of ranibizumab versus laser photocoagulation for retinopathy of prematurityJinfeng Zhao, Zhenquan Wu, Waiching Lam, Mingmin Yang, Lu Chen, Lei Zheng, Fuyan Zhang, Jian Zeng, Jiantao Wang, Guoming Zhang
12 February 2020
Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! projectVincent Daien, Vuong Nguyen, Rohan W Essex, Robin Guymer, Jennifer J Arnold, Marion Munk, Lala Ceklic, Mark C Gillies, Daniel Barthelmes
16 December 2019
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathyKhaled Romdhane, Marta Zola, Alexandre Matet, Alejandra Daruich, Martine Elalouf, Francine Behar-Cohen, Irmela Mantel
15 October 2019
